Allspring Global Investments’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,772
Closed -$44.1K 2546
2024
Q1
$44.1K Buy
+4,772
New +$42K ﹤0.01% 1970
2023
Q3
Sell
-88
Closed -$987 2914
2023
Q2
$987 Buy
+88
New +$780 ﹤0.01% 2663
2023
Q1
Sell
-1,201
Closed -$11.6K 2960
2022
Q4
$11.6K Sell
1,201
-27
-2% -$304 ﹤0.01% 2687
2022
Q3
$15K Buy
1,228
+75
+7% +$915 ﹤0.01% 2670
2022
Q2
$11K Sell
1,153
-4,007
-78% -$44.3K ﹤0.01% 2571
2022
Q1
$65K Buy
+5,160
New +$78.8K ﹤0.01% 2815

Other funds holding ENFN

Allspring Global Investments's ENFN Position: Q2 2024 in Review

Allspring Global Investments sold out of Enfusion, Inc. (ENFN) in Q2 2024, closing a stake of 4,772 shares — an estimated $44.1K sold.

Allspring Global Investments first reported a position in ENFN in Q1 2022 and held it in 6 quarters. The position peaked at $65K in Q1 2022. 101 funds tracked by Wall St. Rank hold ENFN as of Q2 2024.

  • Allspring Global Investments reported no remaining Enfusion, Inc. position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 4,772 Enfusion, Inc. shares in Q2 2024, an estimated $44.1K.
  • Allspring Global Investments first reported a position in Enfusion, Inc. in Q1 2022 and held it in 6 quarters.
  • Allspring Global Investments's Enfusion, Inc. position peaked at $65K in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.